Abstract
Breast cancer is the most common cancer in women in US, and has the second highest mortality rate that accounts for about 25% of all cancer deaths. It has been recognized that genetic biomarkers for cancer are useful for estimating the cancer recurrence risk, and guiding targeted treatment of cancer. Since breast cancers carry a wide spectrum of gene mutations in their genomes, identification of these mutations would be promising in improving diagnosis and treatment of breast cancers. The rapid advances in Next-Generation Sequencing (NGS) technology have generated a large amount of NGS data on breast cancer genomes that makes detection and application of mutant biomarkers for breast cancer a reality. This study performed a wide survey of mutation status of cancer genes in breast cancers based on The Cancer Genome Atlas (TCGA) breast cancer data. Some frequently mutant genes in breast cancers were detected and analyzed.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Next Generation Sequencing & Applications
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
